Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY: DGX )

160.44 +3.60 (+2.30%)
Official Closing Price Updated: 7:00 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Quest Diagnostics

< Previous 1 2 Next >
Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy
From Lisata Therapeutics, Inc.; Quest Diagnostics, Haystack Oncology
Via GlobeNewswire
Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including 
Via MarketBeat
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
Making Connections To Care: Quest Supports Inspiring Health Equity Event Hosted by Sisters on the Vineyard
Via ACCESSWIRE
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
Via MarketBeat
Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing
From Ultima Genomics
Via Business Wire
Quest Diagnostics Inc. (NYSE: DGX) Highlighted for Surprising Price Action
Via Investor Brand Network
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END 
Via FinancialNewsMedia
Exact Sciences Serves Investors Exactly What They Wished For
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The 
Via MarketBeat
UiPath is a Cheaper and More Profitable AI Stock
With the mainstream popularity of ChatGPT, artificial intelligence (AI) has been all the rage in 2023. The AI wars between Microsoft Co. (NASDAQ: MSFT) invest 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Quest Diagnostics Inc. (NYSE: DGX) Making Surprising Moves in Friday Session
Via Investor Brand Network
DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test
From DermTech, Inc.
Via Business Wire
Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio
Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022. 
Via MarketBeat
Exposures COVID-19
Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Technology Awards
From Achievers
Via Business Wire
Rite Aid and Quest Diagnostics Expand Access to COVID-19 PCR Testing Nationwide
From Rite Aid Corporation
Via Business Wire
Quest Diagnostics CHRO Receives "CHRO Lifetime Achievement Award"
SOURCE: Quest Diagnostics 
Via 3BL Media
Exposures COVID-19
ConferMED Awarded Grant From the Quest Diagnostics Foundation To Provide Specialty eConsults to Front Line Providers at Federally Qualified Health Centers in Key Regions
SOURCE: Quest Diagnostics 
Via 3BL Media
Quest for Health Equity Offers No Cost Wellness Screenings at Baltimore Community Event
SOURCE: Quest Diagnostics 
Via 3BL Media
Quest Diagnostics Incorporated (NYSE:DGX) Shareholder Notice: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 05/12/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Quest Diagnostics Incorporated. 
Via SBWire
Quest Diagnostics Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence
SOURCE: Quest Diagnostics 
Via 3BL Media
Quest Diagnostics Incorporated (NYSE:DGX) Investor Notice: Investigation over Possible Securities Laws Violations
San Diego, CA -- (SBWIRE) -- 03/23/2022 -- Quest Diagnostics Incorporated was under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
FORTUNE Magazine Names Quest Diagnostics One of 2022 "World's Most Admired Companies" For Eighth Consecutive Year
SOURCE: Quest Diagnostics 
Via 3BL Media
Development of Novel Innovative Diagnostic tests Generating Huge Revenue Opportunity for Global Blood Testing Market
Palm Beach, FL – February 16, 2022 – FinancialNewsMedia.com News Commentary – The global blood testing market has grown during the pandemic and is expected to continue to rise in the coming years.... 
Via FinancialNewsMedia
Exposures COVID-19
Walmart and Quest Diagnostics Empower People to Take Control of Their Healthcare Through New Consumer-Initiated Laboratory Testing Solution Powered by QuestDirect™ Through Walmart.com
SOURCE: Quest Diagnostics 
Via 3BL Media
Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Sixth Consecutive Year
SOURCE: Quest Diagnostics 
Via 3BL Media
Project HOPE Awarded Grant to Reduce Transmission of COVID-19 Variants in Long-term Care Facilities
SOURCE: Quest Diagnostics 
Via 3BL Media
Exposures COVID-19
Quest Diagnostics Earns Gold Status in American Heart Association's 2021 Workplace Health Achievement Index
SOURCE: Quest Diagnostics 
Via 3BL Media
Quest Announces Annual Sustainability Awards
SOURCE: Quest Diagnostics 
Via 3BL Media
Topics Emissions
Exposures COVID-19
Quest Provides Needed Support for Global Anti-Hate Summit
SOURCE: Quest Diagnostics 
Via 3BL Media
Exposures COVID-19
Rising Cases of Early-Onset Colorectal Cancer Calls for Expanded Biotech Screening Methods
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – December 1, 2021 – Early onset colorectal cancer is currently on the rise [[1]], according to a new study [[2]] from the... 
Via FinancialNewsMedia
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.